CellTivity Scientific
Waltham
About CellTivity Scientific
CellTivity Scientific develops diagnostic imaging technology that enables real-time assessment of metabolic activity in biopsy tissue. The company's flagship offering, Van Gogh, uses a method called Dynamic Cell Imaging (DCI) to generate metabolic “heat maps” of freshly excised samples, helping proceduralists rapidly assess whether a biopsy contains lesions without relying on traditional staining or lengthy pathology processes. The technology integrates with existing workflows’particularly bronchoscopy’to confirm lesion-in-tool, reduce indeterminate biopsies, and improve diagnostic yield. CellTivity’s tools preserve tissue integrity so samples remain usable for downstream analyses such as histology and next-generation sequencing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $25.8M
- Last round: Debt Financing (Oct 2023)
- Website: celltivity.com
- Phone: (781) 472-2500
Industries & Categories
Biotechnology, Health Care, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/celltivity-scientific-125599 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.